India  

Global trial fast tracks testing of hydroxychloroquine, other COVID-19 therapies

Science Daily Thursday, 9 April 2020
A novel 'learning while doing' clinical trial approach called REMAP helps doctors find the optimal trade-off between quickly adopting new therapies during a pandemic, such as the anti-malarial drug hydroxychloroquine, and waiting until they are tested in longer clinical trials. The trial learns from similar trials enrolling around the world and uses artificial intelligence to quickly arrive at answers.
0
shares
ShareTweetSavePostSend
 

Related videos from verified sources

WHO Puts The Brakes On Hydroxychloroquine Trials [Video]

WHO Puts The Brakes On Hydroxychloroquine Trials

The World Health Organization is pausing clinical trials of hydroxychloroquine as a possible treatment for the novel coronavirus COVID-19. According to Business Insider, the WHO's steering committee of..

Credit: Wochit Business     Duration: 00:35Published
UK health workers begin hydroxychloroquine trial [Video]

UK health workers begin hydroxychloroquine trial

British healthcare workers will on Thursday begin taking part in a University of Oxford-led international trial of two anti-malarial drugs to see if they can prevent COVID-19, including one U.S...

Credit: Reuters Studio     Duration: 01:25Published

Tweets about this